Partial
Partially Aligned
Patient Risk:
Moderate
Summary
The claims partially reflect the label’s general interaction concern between ibuprofen and aspirin (including interference with antiplatelet activity and potential increased adverse effects/GI bleeding), but most asserted practical timing rules (e.g., 30 minutes, 8 hours, “close together” risk framing) and indication-specific timing differences are not supported by the provided FDA labeling excerpts.
Category Scores
Accurate Statements
Ibuprofen can interfere with aspirin’s antiplatelet (platelet) activity when taken with low-dose aspirin, particularly when ibuprofen is administered before aspirin (pharmacodynamic interference).
DRUG INTERACTIONS: interference with aspirin antiplatelet activity; interaction exists even with once-daily ibuprofen 400 mg; particularly when ibuprofen is dosed prior to aspirin.
Concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects.
DRUG INTERACTIONS: concomitant administration of ibuprofen and aspirin is not generally recommended due to potential increased adverse effects.
Ibuprofen adverse reactions include gastrointestinal complaints and serious GI events such as gastric/duodenal ulcer with bleeding and/or perforation and GI hemorrhage/melena.
ADVERSE REACTIONS: frequent GI reactions; table includes gastric/duodenal ulcer with bleeding and/or perforation, gastrointestinal hemorrhage, and melena.
Unsupported Statements
Timing matters more when aspirin is used for heart or stroke prevention than when aspirin is used for pain or fever.
No provided label excerpt supports differential timing importance by aspirin indication.
Many clinicians recommend separating doses of ibuprofen and aspirin used for heart or stroke prevention so aspirin can work properly.
No provided label excerpt includes clinician-recommendation language to separate doses.
A practical approach is to take aspirin first and wait at least about 30 minutes before taking ibuprofen.
No provided label excerpt gives a ~30-minute interval guidance.
If ibuprofen is taken first, a buffer of about 8 hours is commonly used before taking aspirin...
No provided label excerpt specifies an 8-hour buffer.
If aspirin is used for pain or fever rather than platelet/heart protection, timing is usually less critical.
No provided label excerpt addresses aspirin use for pain/fever versus cardio protection or relative timing criticality.
Combining NSAIDs and aspirin-like effects raises concerns about excessive dosing...
Label excerpt supports increased adverse effects, but does not specifically mention 'excessive dosing' as the concern.
People should generally avoid taking ibuprofen and aspirin at the same time...
Label excerpt supports not generally recommending concomitant administration, but does not explicitly state 'avoid at the same time' as patient-facing timing guidance.
Taking ibuprofen and aspirin close together can increase the risk of kidney strain, especially in older adults, dehydration, or kidney disease.
Provided excerpts do not link ibuprofen+aspirin timing/coadministration to renal risk, nor do they specify older adults/dehydration/kidney disease in this context.
Taking ibuprofen and aspirin close together can increase the risk of bruising/bleeding if the person is already at higher bleeding risk.
Label excerpts provided discuss bleeding risk with antiplatelet interference and warfarin-type anticoagulants/NSAID synergy, but do not support this 'close together' timing mechanism or 'higher bleeding risk' condition in the asserted form.
Black/tarry stools are a sign of bleeding.
Label excerpt includes 'melena' but does not explicitly equate it to 'black/tarry stools' as a patient-facing statement.
Vomiting blood is a sign of bleeding.
Provided excerpts do not mention hematemesis ('vomiting blood').
Severe stomach pain is a warning sign that warrants urgent medical advice if occurring with ibuprofen and aspirin close together.
Provided excerpts do not include an urgent-medical-advice instruction tied to 'close together' dosing.
Allergic symptoms warrant urgent medical advice if occurring with ibuprofen and aspirin close together.
Provided excerpts list allergic severe reactions (e.g., anaphylaxis) but do not provide the stated 'urgent medical advice' instruction nor tie it to timing with aspirin.
Timing guidance may differ for people taking blood thinners such as warfarin, apixaban, or rivaroxaban.
Provided excerpt discusses warfarin-type anticoagulants; apixaban and rivaroxaban timing guidance is not supported by provided label excerpts.
Timing guidance may differ for people with a history of ulcers or GI bleeding.
Provided excerpts do not include timing guidance conditional on ulcer/GI bleeding history.
Timing guidance may differ for people with kidney disease.
Provided excerpts do not include timing guidance conditional on kidney disease status.
Timing guidance may differ for people taking aspirin for a specific cardiac indication (stent, prior heart attack, or prior stroke).
Provided excerpts refer broadly to low-dose aspirin for cardio protection and do not specify stent/prior MI/prior stroke timing guidance.
Contradictions
Important Omissions
Specific label-supported mitigation for the aspirin/ibuprofen antiplatelet interference includes that the interaction is alleviated if immediate-release low-dose aspirin is dosed at least 2 hours prior to once daily ibuprofen (and that this cannot be extended to enteric-coated aspirin).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Multiple asserted numeric timing buffers and patient-facing urgent/conditional guidance are not supported by the provided label excerpts; this may lead to dosing decisions that are not label-aligned. However, core concepts that ibuprofen can interfere with aspirin antiplatelet activity and that GI bleeding risk/serious GI adverse reactions exist with aspirin/NSAID coadministration are directionally consistent with the provided labeling excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Unlabeled numeric timing rules and indication-specific/condition-specific timing differences are asserted without support in the provided label excerpts.
Suggested Improvement
Replace numeric timing buffers (e.g., 30 minutes, 8 hours) and indication/condition-specific timing comparisons with the specific label-supported interaction mitigation details (e.g., immediate-release low-dose aspirin at least 2 hours prior to once daily ibuprofen) and limit statements to what the provided excerpts support.